1,567
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Polygonum cuspidatum inhibits the growth of osteosarcoma cells via impeding Akt/ERK/EGFR signaling pathways

, , , , , & ORCID Icon show all
Pages 2992-3006 | Received 08 Nov 2021, Accepted 07 Dec 2021, Published online: 07 Feb 2022

References

  • Gianferante DM, Mirabello L, Savage SA. Germline and somatic genetics of osteosarcoma- connecting aetiology, biology and therapy. Nat Rev Endocrinol. 2017;13:480–491.
  • Gill J, Ahluwalia MK, Geller D, et al. New targets and approaches in osteosarcoma. Pharmacol Ther. 2013;137:89–99.
  • Dai H, Lv Y, Yan G, et al. RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma. Cell Death Dis. 2016;7:e2572.
  • Zohreh JA, Mohammad JA, Ali AA. Overexpression of CDC7 in malignant sali-vary gland tumors correlates with tumor differentiation. Braz J Otorhinolaryngol. 2019;85:144–149.
  • Kuijjer ML, Hogendoorn PC, Cleton-Jansen AM. Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor. Int J Cancer. 2013;133:2512–2521.
  • Zhu K, Ma X, Zhang C. LncRNA ODRUL contributes to osteosarcoma progression through the miR-3182/MMP2 axis. Mol Ther. 2017;25:2383–2393.
  • Wang S, Luo S, Liu C, et al. miR-491 inhibits osteosarcoma lung metastasis and chemoresistance by targeting αB-crystallin. Mol Ther. 2017;25:2140–2149.
  • Berlanga P, Muñoz L, Piqueras M, et al. Llombart-Bosch, miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis. Mol Oncol. 2016;10:1043–1053.
  • Xu H, Deng Y, Zhou Z, et al. Chinese herbal medicine (Chaihu-Huaji Decoction) alleviates postembolization syndrome following transcatheter arterial chemoembolization and improves survival in unresectable hepatocellular cancer: a retrospective study. Evid Based Complement Alternat Med. 2019;6269518. DOI:10.1155/2019/6269518
  • Tang J, Liu B, Ma K. Traditional Chinese medicine. Lancet. 2008;372:1938–1940.
  • Wang R, Liu H, Shao Y, et al. Sophoridine inhibits human colorectal cancer progression via targeting MAPKAPK2. Mol Cancer Res. 2019;17:2469–2479.
  • Zhang A, Sun H, Qiu S, et al. Advancing drug discovery and development from active constituents of yinchenhao tang, a famous traditional Chinese medicine formula. Evid Based Complement Alternat Med. 2013;257909. DOI:10.1155/2013/257909
  • Hopkins AL. Network pharmacology. Nature Biotechnology. 2007;25(10):1110–1111.
  • Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4:682–690.
  • Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11:110–120.
  • Wu X, Wu C. Network pharmacology: a new approach to unveiling traditional Chinese medicine. Chin J Nat Med. 2015;13:1–2.
  • Pan Y, Chen Y, Wu C, et al. Network pharmacology-guided mechanism study uncovers inhibitory effect of Mahuang Decoction on lung cancer growth by impeding Akt/ERK signaling pathways. Am J Trans Res. 2021;13:2094–2110.
  • Zhang G, Li Q, Chen Q, et al. Network pharmacology: a new approach for Chinese herbal medicine research. Evid Based Complement Alternat Med. 2013;621423. DOI:10.1155/2013/621423
  • Yi T, Zhang H, Cai Z. Analysis of rhizoma polygoni cuspidati by HPLC and HPLC-ESI/MS. Phytochem Anal. 2007;18:387–392.
  • Sheng Z, Ai B, Zheng L, et al. Capability of polygonum cuspidatum extract in inhibiting AGEs and preventing diabetes. Food Sci Nutr. 2019;7:2006–2016.
  • Lin Y, Yang F, Chen C, et al. Free radical scavenging activity and antiproliferative potential of polygonum cuspidatum root extracts. J Nat Med-Tokyo. 2010;64:146–152.
  • Feng L, Zhang L, Yan T, et al. Studies on active substance of anticancer effect in polygonum cuspidatum. J Chin Med Mater (Chinese Journal). 2006;29:689–691.
  • Pan B, Shi X, Ding T, et al. Unraveling the action mechanism of polygonum cuspidatum by a network pharmacology approach. Am J Transl Res. 2019;11:6790–6811.
  • Pan B, Wang Y, Wu C, et al. A mechanism of action study on Danggui Sini Decoction to discover its therapeutic effect on gastric cancer. Front Pharmacol. 2021;11:592903.
  • Liu Y, Grimm M, Dai W, et al. CB-Dock: a web server for cavity detection-guided protein-ligand blind docking. Acta Pharmacol Sin. 2020;41:138–144.
  • Chen Z, Wang P. Clinical distribution and molecular basis of traditional Chinese medicine ZHENG in cancer. Evid Based Compl Alt. 2012;783923.
  • Pan B, Zang J, He J, et al. Add-On therapy with Chinese herb medicine Bo-Er-Ning capsule (BENC) improves outcomes of gastric cancer patients: a randomized clinical trial followed with bioinformatics-assisted mechanism study. Am J Cancer Res. 2018;8:1090–1105.
  • Pan B, Fang S, Zhang J, et al. Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. Comput Struct Biotec. 2020;18:3518–3527.
  • Pan B, Ren Y, Liu L. Uncovering the action mechanism of polydatin via network pharmacological target prediction. RSC Adv. 2018;8:18851–18858.
  • Zou J, Yang Y, Yang Y, et al. Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway. Biomedicine & Pharmacotherapy. 2018;108:130–136.
  • Li H, Shi B, Li Y, et al. Polydatin inhibits cell proliferation and induces apoptosis in laryngeal cancer and HeLa cells via suppression of the PDGF/AKT signaling pathway. J Biochem Mol Toxicol. 2017;31. Epub 2017 Mar 7. DOI:10.1002/jbt.21900
  • Ward AB, Mir H, Kapur N, et al. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J Surg Oncol. 2018;16:108.
  • Lin W, Zhong M, Yin H, et al. Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo. Oncol Rep. 2016;36:961–967.
  • Shen F, Ge C, Yuan P. Aloe-emodin induces autophagy and apoptotic cell death in non-small cell lung cancer cells via Akt/mTOR and MAPK signaling. Eur J Pharmacol. 2020;886:173550.
  • Chai R, Fu H, Zheng Z, et al. Resveratrol inhibits proliferation and migration through SIRT1 mediated post-translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells. Mol Med Rep. 2017;16:8037–8044.